Skip to main content
Equibles

ANTHEM · Anthem Biosciences Limited

Use ANTHEM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ANTHEM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
938.50 INR -19.30 (-2.02%) At close · Nov 12
Rebalance outlook locked
Volume · Nov 12 40.76K Avg daily vol (3M) 146.87K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close938.50 INR Open955.95 INR Day930.40–961.95 INR 52W close592.05–958.90 INR Avg vol 30d192K Last earningsNov 4, 2026 DataJul 2025–Nov 2026

Latest documents

2026
Nov 4
Earnings call
Q2 revenue reaches INR594 crores with 50.6% EBITDA margin

Anthem Biosciences reported Q2 FY27 consolidated revenue from operations of INR594 crores, EBITDA of INR330 crores at a 50.6% margin, and PAT of INR211 crores at a 32.04% margin.

3 source passages
First of all, we are pleased to report a robust performance for Q2 FY27, with consolidated revenue from operations going up to INR594 crores for the quarter. The EBITDA was INR330 crores, with EBITDA margins at 50.6%. PBT was INR296 crores, while PAT, that is profit after tax, was INR211 crores, with PAT margins at 32.04%. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
· 5.40B INR 0 INR '26 Q1 · 5.50B INR 0 INR '26 Q2 · 4.23B INR 0 INR '26 Q3 · 6.11B INR 1.90B INR '26 Q4 ▼22.6% 4.18B INR 0 INR '27 Q1 LATEST ▲8% 5.94B INR 0 INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 592.05 INR Now 938.50 INR · 94% Range high 958.90 INR
vs 200-day avg +20% vs 50-day avg +6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:ANTHEM +2.7% +10.7% +22.0% +13.3% +44.2%

Exchange listing

Market
XBOM
Ticker
ANTHEM
ISIN
INE0CZ201020
Security
Ordinary share
Trading currency
INR

Company

Website
https://anthembio.com/
Investor relations
https://anthembio.com/investors-disclaimer/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-06-25 2.00 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-04 Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-07-22 Audio Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-20 Audio Transcript
    Anthem Biosciences Limited Q4 & FY26 Earnings Conference Call
  • Earnings call · Q3 2026 2026-02-05 Audio Transcript
    “Anthem Biosciences Limited Q3 & 9M FY26 Earning Conference Call”